SSRIs double the risk of suicide and violence in healthy adults
BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5504 (Published 12 October 2016) Cite this as: BMJ 2016;355:i5504- Ingrid Torjesen
- London
Selective serotonin and serotonin-norepinephrine (noradrenaline) reuptake inhibitors double the risk of suicide and violence in healthy adults with no signs of a mental disorder, a systematic review has found.
The review, published in the Journal of the Royal Society of Medicine, is the first to analyse trials of these antidepressants in healthy adults.1 Researchers from the Nordic Cochrane Centre and University of Copenhagen in Denmark identified 130 double blind, randomised placebo controlled trials through PubMed and Embase and 29 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.